AEterna Zentaris (AEZS) Competitor Comparison
We are evaluating the key criteria listed to compare AEterna Zentaris (AEZS) against its competitors in the Biotechnology industry.
Market Capitalization
345 / 368Gross Profits
0 / 278Total Revenue
194 / 300EBITDA
67 / 337Free Cashflow
90 / 352Quick Ratio
88 / 357Earnings per Share
226 / 359Dividend yield
0 / 6Total Cash
275 / 358Performance 3 years
7 / 368Performance 5 years
6 / 368Performance 10 years
11 / 368Linearity 3 years
338 / 368Linearity 5 years
332 / 368Linearity 10 years
332 / 368Total Rank
45 / 368Dividend Rank
336 / 368Valuation Rank
345 / 368Piotroski Rank
64 / 368Muliplier Rank
256 / 368Market Capitalization - AEZS ranking 345 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.